A detailed history of Tcw Group Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tcw Group Inc holds 37,282 shares of BMY stock, worth $1.96 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
37,282
Previous 36,908 1.01%
Holding current value
$1.96 Million
Previous $2 Million 22.64%
% of portfolio
0.01%
Previous 0.02%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$40.25 - $52.99 $15,053 - $19,818
374 Added 1.01%
37,282 $1.55 Million
Q1 2024

May 09, 2024

SELL
$47.98 - $54.4 $227,425 - $257,856
-4,740 Reduced 11.38%
36,908 $2 Million
Q4 2023

Feb 09, 2024

BUY
$48.48 - $57.85 $2.02 Million - $2.41 Million
41,648 New
41,648 $2.14 Million
Q1 2020

May 05, 2020

SELL
$46.4 - $67.43 $2.31 Million - $3.35 Million
-49,702 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $769,792 - $1 Million
15,643 Added 45.93%
49,702 $3.19 Million
Q2 2019

Aug 07, 2019

BUY
$44.62 - $49.34 $307,878 - $340,446
6,900 Added 25.41%
34,059 $1.55 Million
Q3 2018

Oct 30, 2018

SELL
$55.19 - $62.25 $386 - $435
-7 Reduced 0.03%
27,159 $1.69 Million
Q1 2018

May 11, 2018

BUY
$59.92 - $68.98 $104,860 - $120,715
1,750 Added 6.89%
27,166 $1.72 Million
Q2 2017

Aug 11, 2017

BUY
N/A
25,416
25,416 $1.42 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $112B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Tcw Group Inc Portfolio

Follow Tcw Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tcw Group Inc with notifications on news.